Dr. Eric Bouffet, MD
Claim this profileThe Hospital for Sick Children (SickKids)
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
7 reported clinical trials
10 drugs studied
Area of expertise
1Brain Tumor
NTRK positive
IDH positive
H3 K27 positive
2Diffuse Intrinsic Pontine Glioma
NTRK positive
IDH positive
H3 K27 positive
Affiliated Hospitals
Clinical Trials Eric Bouffet, MD is currently running
Ribociclib + Everolimus
for Brain Tumors
This trial is testing whether the combination of ribociclib and everolimus can help children and young adults with aggressive brain tumors live longer. Everolimus is a medication that has been approved for treating various cancers. These drugs are taken by mouth and work by stopping cancer cells from growing. The study focuses on patients whose tumors have specific genetic changes that make them hard to treat with standard therapies.
Recruiting1 award Phase 2
ACTEMRA
for Pediatric Craniopharyngioma
This trial tests ACTEMRA, a drug that blocks a protein called IL-6, in children with a recurring brain tumor called ACP. The goal is to see if it can reduce tumor growth and improve their quality of life.
Recruiting1 award Phase 235 criteria
More about Eric Bouffet, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Eric Bouffet, MD has experience with
- Targeted Pediatric High-Grade Glioma Therapy
- Ribociclib
- Everolimus
- Temozolomide
- Olutasidenib
- Larotrectinib
Breakdown of trials Eric Bouffet, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Subependymal Giant Cell Astrocytoma
Anaplastic astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Bouffet, MD specialize in?
Eric Bouffet, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved NTRK positive patients, or patients who are IDH positive.
Is Eric Bouffet, MD currently recruiting for clinical trials?
Yes, Eric Bouffet, MD is currently recruiting for 4 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Eric Bouffet, MD has studied deeply?
Yes, Eric Bouffet, MD has studied treatments such as Targeted Pediatric High-Grade Glioma Therapy, Ribociclib, Everolimus.
What is the best way to schedule an appointment with Eric Bouffet, MD?
Apply for one of the trials that Eric Bouffet, MD is conducting.
What is the office address of Eric Bouffet, MD?
The office of Eric Bouffet, MD is located at: The Hospital for Sick Children (SickKids), Toronto, Ontario M5G1X8 Canada. This is the address for their practice at the The Hospital for Sick Children (SickKids).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.